High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study-Reference-Cited by-同舟云学术

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study

Published:2009-06 Issue:6 Volume:50 Page:1084-1092
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Moucari Rami,Korevaar Anneke,Lada Olivier,Martinot-Peignoux Michelle,Boyer Nathalie,Mackiewicz Vincent,Dauvergne Agnes,Cardoso Ana C.,Asselah Tarik,Nicolas-Chanoine Marie-Hélène,Vidaud Michel,Valla Dominique,Bedossa Pierre,Marcellin Patrick

Publisher

Elsevier BV

Subject

Hepatology

Reference33 articles.

1. Management of hepatitis B: summary of a clinical research workshop;Hoofnagle;Hepatology,2007

2. Current treatment of hepatitis B;Dusheiko;GUT,2008

3. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;Lau;N Engl J Med,2005

4. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;Janssen;Lancet,2005

5. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation;European Journal of Gastroenterology & Hepatology;2024-07-22

2. Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function;Virology Journal;2024-03-30

3. Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy;Antiviral Research;2024-01

4. Mesencephalic Astrocyte-derived Neurotrophic Factor Supports Hepatitis B Virus-induced Immunotolerance;Cellular and Molecular Gastroenterology and Hepatology;2024

5. Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function;2023-11-10